Amgen, CVS propel bonds sales to monthly record.
The CVS sale consisted of $1.75 billion of notes due in 2010 that pay interest at 30 basis points more than the three-month London interbank offered rate (LIBOR); $1.75 billion of 5.75% securities due in 2017; $1 billion of 6.25% bonds due in 2027; and $1 billion of so-called hybrid bonds due in 2062. Amgen sold $2 billion of 18-month floating-rate notes; $1.1 billion of 5.85% 10-year fixed-rate securities and $900 million of 6.375% 30-year bonds.
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||TOP STORIES|
|Article Type:||Brief article|
|Date:||Jun 4, 2007|
|Previous Article:||Novacea Inc. (Nasdaq) led advancing issues, soaring $6.06, or 85% on the week, to $13.16.|
|Next Article:||Democratic presidential candidate Barack Obama announced a plan last week to provide universal health care in the U.S. by 2012, to be paid chiefly by...|